de O Viana J, Weber K, da Cruz L, Santos R, Rocha G, Jordao A
ACS Omega. 2025; 10(1):306-317.
PMID: 39829523
PMC: 11740253.
DOI: 10.1021/acsomega.4c06146.
Wan Y, Wu J, Hou T, Hsieh C, Jia X
Nat Commun. 2025; 16(1):413.
PMID: 39762223
PMC: 11704287.
DOI: 10.1038/s41467-024-55082-4.
Shen W, Cui C, Su X, Zhang Z, Velez-Arce A, Wang J
Res Sq. 2024; .
PMID: 39678335
PMC: 11643338.
DOI: 10.21203/rs.3.rs-2988283/v2.
Nandi R, Sharma A, Priya A, Kumar D
Mol Divers. 2024; .
PMID: 39653961
DOI: 10.1007/s11030-024-11070-w.
Choudhary R, Mahadevan R
ACS Med Chem Lett. 2024; 15(7):1057-1070.
PMID: 39015268
PMC: 11247655.
DOI: 10.1021/acsmedchemlett.4c00148.
iSIM: instant similarity.
Lopez-Perez K, Kim T, Alain Miranda-Quintana R
Digit Discov. 2024; 3(6):1160-1171.
PMID: 38873032
PMC: 11167700.
DOI: 10.1039/d4dd00041b.
Benchmarking compound activity prediction for real-world drug discovery applications.
Tian T, Li S, Zhang Z, Chen L, Zou Z, Zhao D
Commun Chem. 2024; 7(1):127.
PMID: 38834746
PMC: 11150475.
DOI: 10.1038/s42004-024-01204-4.
Molecular property prediction based on graph structure learning.
Zhao B, Xu W, Guan J, Zhou S
Bioinformatics. 2024; 40(5).
PMID: 38710497
PMC: 11112045.
DOI: 10.1093/bioinformatics/btae304.
Protein characteristics substantially influence the propensity of activity cliffs among kinase inhibitors.
Daoud S, Taha M
Sci Rep. 2024; 14(1):9058.
PMID: 38643174
PMC: 11032345.
DOI: 10.1038/s41598-024-59501-w.
Discovery and optimization of narrow spectrum inhibitors of Tousled like kinase 2 (TLK2) using quantitative structure activity relationships.
Asquith C, East M, Laitinen T, Alamillo-Ferrer C, Hartikainen E, Wells C
Eur J Med Chem. 2024; 271:116357.
PMID: 38636130
PMC: 11421834.
DOI: 10.1016/j.ejmech.2024.116357.
3D molecular generative framework for interaction-guided drug design.
Zhung W, Kim H, Kim W
Nat Commun. 2024; 15(1):2688.
PMID: 38538598
PMC: 10973397.
DOI: 10.1038/s41467-024-47011-2.
Discovery and Optimization of Narrow Spectrum Inhibitors of Tousled Like Kinase 2 (TLK2) Using Quantitative Structure Activity Relationships.
Asquith C, East M, Laitinen T, Alamillo-Ferrer C, Hartikainen E, Wells C
bioRxiv. 2024; .
PMID: 38234837
PMC: 10793458.
DOI: 10.1101/2023.12.28.573261.
The Good, The Bad, and The Perplexing: Structural Alerts and Read-Across for Predicting Skin Sensitization Using Human Data.
Golden E, Ukaegbu D, Ranslow P, Brown R, Hartung T, Maertens A
Chem Res Toxicol. 2023; 36(5):734-746.
PMID: 37126467
PMC: 10189792.
DOI: 10.1021/acs.chemrestox.2c00383.
A consensual machine-learning-assisted QSAR model for effective bioactivity prediction of xanthine oxidase inhibitors using molecular fingerprints.
Wu Y, Li M, Shen J, Pu X, Guo Y
Mol Divers. 2023; 28(4):2033-2048.
PMID: 37043162
DOI: 10.1007/s11030-023-10649-z.
A Perspective on Explanations of Molecular Prediction Models.
Wellawatte G, Gandhi H, Seshadri A, White A
J Chem Theory Comput. 2023; 19(8):2149-2160.
PMID: 36972469
PMC: 10134429.
DOI: 10.1021/acs.jctc.2c01235.
In Silico Tools to Extract the Drug Design Information Content of Degradation Data: The Case of PROTACs Targeting the Androgen Receptor.
Apprato G, DAgostini G, Rossetti P, Ermondi G, Caron G
Molecules. 2023; 28(3).
PMID: 36770875
PMC: 9919651.
DOI: 10.3390/molecules28031206.
Large-scale prediction of activity cliffs using machine and deep learning methods of increasing complexity.
Tamura S, Miyao T, Bajorath J
J Cheminform. 2023; 15(1):4.
PMID: 36611204
PMC: 9825040.
DOI: 10.1186/s13321-022-00676-7.
Design of MMP-1 inhibitors via SAR transfer and experimental validation.
Umedera K, Yoshimori A, Bajorath J, Nakamura H
Sci Rep. 2022; 12(1):20915.
PMID: 36463250
PMC: 9719525.
DOI: 10.1038/s41598-022-25079-4.
Exposing the Limitations of Molecular Machine Learning with Activity Cliffs.
van Tilborg D, Alenicheva A, Grisoni F
J Chem Inf Model. 2022; 62(23):5938-5951.
PMID: 36456532
PMC: 9749029.
DOI: 10.1021/acs.jcim.2c01073.
Navigating Transcriptomic Connectivity Mapping Workflows to Link Chemicals with Bioactivities.
Shah I, Bundy J, Chambers B, Everett L, Haggard D, Harrill J
Chem Res Toxicol. 2022; 35(11):1929-1949.
PMID: 36301716
PMC: 10483698.
DOI: 10.1021/acs.chemrestox.2c00245.
